Incidence and Long term impact of postoperative Acute Kidney Injury in patients undergoing major abdominal surgery (IMPACT PO-AKI)
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 174
- 试验地点
- 1
- 主要终点
- Incidence of PO-AKI (an acute alteration in kidney function) within 7 days in patients undergoing major abdominal surgery including, Hepatic resection, Pancreatic surgery, cytoreductive surgery with or without HIPEC
研究概览
简要总结
Postoperative acute kidney injury (PO-AKI) is a common complication of major surgery that is strongly associated with short-term surgical complications and long-term adverse outcomes, including increased risk of chronic kidney disease cardiovascular events and death.POAKI is best defined as AKI occurring within 7 days of an operative intervention using the Kidney Disease Improving Global Outcomes (KDIGO) definition of AKI. Prevention of PO-AKI is largely based on identification of high baseline risk, monitoring and reduction of nephrotoxic insults, whereas treatment involves the application of a bundle of interventions to avoid secondary kidney injury and mitigate the severity of AKI.
Acute Kidney injury (AKI) is described as an abrupt and reversible decline in the glomerular filtration rate (GFR) which results in an elevation of serum blood urea nitrogen (BUN), creatinine and other metabolic waste products that are normally excreted by the kidney. In 2012, Kidney Disease Improving Global Outcomes (KDIGO) described the KDIGO AKI diagnostic criteria and categorized AKI into stages 1–3, determined by changes in serum creatinine and/or urine output.
The risk of developing AKI following emergency major abdominal surgery is 17percent. The risk of renal injury is particularly high in patients treated with cisplatin-containing HIPEC regimens . Incidence of AKI in patients undergoing laparoscopic pancreas surgeries was 11percent . Incidence of PO-AKI in TMH patients undergoing major abdominal cancer surgery was 10percent. Colloids have been associated with acute kidney injury. Recently, there has been a change in departmental fluid policy i.e. no use of colloids in the perioperative period, therefore we planned this prospective observational study was to study the incidence of PO-AKI.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18.00 Year(s) 至 99.00 Year(s)(—)
- 性别
- All
入选标准
- •Consenting patients more than 18 years of age, undergoing elective major abdominal surgeries including Liver, pancreatic, cytoreductive surgery with or without HIPEC.
- •Patients undergoing open, laparoscopic, laparoscopic-assisted, laparoscopic converted and robotic procedures.
排除标准
- •Patients not willing to consent
- •Patients undergoing surgical procedures other than those mentioned above
- •Patients undergoing planned or unplanned nephrectomy
- •Patients with pre-existing renal disease (previous history of AKI according to KDIGO criteria)
- •Post kidney transplant patient
- •Patients with end stage kidney disease on dialysis.
- •Renal replacement therapy (any form of dialysis) within the 90 days preceding the operation.
结局指标
主要结局
Incidence of PO-AKI (an acute alteration in kidney function) within 7 days in patients undergoing major abdominal surgery including, Hepatic resection, Pancreatic surgery, cytoreductive surgery with or without HIPEC
时间窗: Within first 7 days after surgery
次要结局
- 1. Incidence of Early PO-AKI ( AKI occurring within 48 hrs after surgery)(2. Incidence of AKD (a sustained alteration in kidney function over a 3-month period i.e. persisting after 7 days until 3 months after surgery))
研究者
Dr Vandana Agarwal
Tata Memorial Hospital
